- Home
- RFL vs ICMB Comparison
RFL vs ICMB Comparison
Compare RFL & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- ICMB
- Stock Information
- Founded
- RFL 2017
- ICMB 2012
- Country
- RFL United States
- ICMB United States
- Employees
- RFL N/A
- ICMB N/A
- Industry
- RFL Real Estate
- ICMB Finance: Consumer Services
- Sector
- RFL Finance
- ICMB Finance
- Exchange
- RFL Nasdaq
- ICMB Nasdaq
- Market Cap
- RFL 48.4M
- ICMB 48.0M
- IPO Year
- RFL N/A
- ICMB N/A
- Fundamental
- Price
- RFL $2.12
- ICMB $3.19
- Analyst Decision
- RFL
- ICMB
- Analyst Count
- RFL 0
- ICMB 0
- Target Price
- RFL N/A
- ICMB N/A
- AVG Volume (30 Days)
- RFL 48.8K
- ICMB 28.4K
- Earning Date
- RFL 10-28-2024
- ICMB 11-11-2024
- Dividend Yield
- RFL N/A
- ICMB 15.05%
- EPS Growth
- RFL N/A
- ICMB N/A
- EPS
- RFL N/A
- ICMB N/A
- Revenue
- RFL $540,000.00
- ICMB $23,878,302.00
- Revenue This Year
- RFL N/A
- ICMB $10.32
- Revenue Next Year
- RFL N/A
- ICMB N/A
- P/E Ratio
- RFL N/A
- ICMB N/A
- Revenue Growth
- RFL 92.86
- ICMB N/A
- 52 Week Low
- RFL $1.29
- ICMB $2.98
- 52 Week High
- RFL $2.14
- ICMB $4.12
- Technical
- Relative Strength Index (RSI)
- RFL 79.87
- ICMB 53.03
- Support Level
- RFL $2.00
- ICMB $3.14
- Resistance Level
- RFL $1.94
- ICMB $3.22
- Average True Range (ATR)
- RFL 0.09
- ICMB 0.08
- MACD
- RFL 0.02
- ICMB 0.01
- Stochastic Oscillator
- RFL 100.00
- ICMB 65.22
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.